title: Antibiotic use in newborns with transient tachypnea of the newborn.
abstract: BACKGROUND
  Initiation of empiric antibiotic treatment for possible early-onset sepsis is recommended for late preterm and term neonates with respiratory distress. There is no evidence base to this approach.
  
  
  OBJECTIVE
  To determine the incidence of adverse infectious events in neonates with transient tachypnea of the newborn (TTN) managed with a risk-factor-based restrictive antibiotic use policy.
  
  
  METHODS
  This is a single institution retrospective cohort study of neonates with primary diagnosis of TTN between 2004 and 2010. The relationship between antibiotic exposure and infectious outcomes during the neonatal hospitalization was evaluated. An infectious outcome was defined as pneumonia, bacteremia, clinical sepsis, or death. Analysis included t test, χ(2) test, and analysis of variance as appropriate.
  
  
  RESULTS
  745 neonates with TTN met inclusion criteria. None of the 494 antibiotic-naive infants, and 212 of the 251 antibiotic-exposed infants had identifiable risk factors for sepsis. No infectious outcomes occurred in infants who did not receive antibiotics. Eight neonates with TTN received full antibiotic treatment for early-onset sepsis. Each was appropriately identified for early receipt of antibiotics based on historical or clinical risk factors for early-onset sepsis.
  
  
  CONCLUSIONS
  This study suggests that empiric postnatal antibiotic treatment may not be warranted for late preterm and term infants with TTN in the absence of specific infectious risk factors.
authors: Division of Newborn Medicine, Kravis Children's Hospital, Mount Sinai Medical Center, New York, NY, USA. andrea.weintraub@mssm.edu
authors: Andrea S
authors: AS
authors: Weintraub
authors: Claudia T
authors: CT
authors: Cadet
authors: Roxane
authors: R
authors: Perez
authors: Elissa
authors: E
authors: DeLorenzo
authors: Ian R
authors: IR
authors: Holzman
authors: Annemarie
authors: A
authors: Stroustrup
mesh_terms: D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D005260:Female; D005865:Gestational Age; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D009519:New York City / Q000453:epidemiology; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D018805:Sepsis / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D059245:Transient Tachypnea of the Newborn / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents